The U.S. Food and Drug Administration (FDA) has launched an urgent recall of several vitamin B12 products sold under multiple brand names after routine testing revealed the presence of an undeclared peanut allergen. The agency issued an official statement on its website on June 12, warning consumers about the potential health risks associated with these supplements.
The recall was triggered after Aldi, a major grocery retailer, identified the peanut allergen during standard quality checks. Because peanuts are a common allergen that can cause severe allergic reactions, the FDA is taking swift action to remove the affected products from store shelves and online marketplaces.
Among the recalled items are vitamin B12 gummies, which have gained popularity as a convenient and tasty supplement option. However, the undeclared allergen in these products poses a significant danger to individuals with peanut allergies, who may suffer from severe reactions if they unknowingly consume the contaminated supplements.
The FDA has urged consumers who have purchased these vitamin B12 products to immediately stop using them and check the product packaging for recall information. Customers should also contact their healthcare providers if they experience any adverse reactions or have concerns about their exposure to peanuts.
Retailers are instructed to remove the recalled items from their inventories and cooperate with the FDA to ensure consumer safety. This recall highlights the importance of strict quality controls and transparent labeling in dietary supplements to protect public health.
The FDA continues to monitor the situation closely and is working with manufacturers and retailers to prevent further distribution of the contaminated products. Consumers are advised to stay updated through official FDA channels for any new information regarding this recall.
Related Topics:
Almarai Acquires Pure Beverages for USD 277M Expansion
